STOCK TITAN
  1. Home
  2. Sec-filings
  3. BATRA
  4. [Form 4] Atlanta Braves Holdings, Inc. Insider Trading Activity

Atlanta Braves Holdings (BATRA) CFO sells 30K shares in plan trade

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. (BATRA/BATRK) reported insider transactions by Jill L. Robinson, EVP, CFO & Treasurer. On August 19, 2026, she exercised options for 30,263 shares of Series C Common Stock at an exercise price of $27.18 per share and then sold 30,263 shares at a weighted average price of $52.84 per share, under a Rule 10b5-1 sales plan adopted on May 18, 2026.

Positive

  • None.

Negative

  • None.
Insider Robinson Jill L.
Role EVP, CFO & Treasurer
Sold 30,263 shs ($1.60M)
Approx. gross sale proceeds $1.60M
Approx. exercise cost $823K
Approx. pre-tax spread $777K
Type Security Shares Price Value
Exercise Stock option (Right to Buy) - BATRK F1 30,263 $0.00 $0.00
Exercise Series C Common Stock 30,263 $27.18 $823K
Sale Series C Common Stock F1, F2 30,263 $52.84 $1.60M
Holdings After Transaction: Stock option (Right to Buy) - BATRK — 0 shares (Direct); Series C Common Stock — 79,460 shares (Direct)
Footnotes (2)
  1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2026.
  2. F2. Reflects the weighted average sale price. The range of prices for such transaction is $52.24 to $53.66. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
Options exercised 30,263 shares Stock option (Right to Buy) - BATRK exercised into Series C Common Stock on August 19, 2026
Option exercise price $27.18 per share Exercise price of stock option for 30,263 underlying Series C Common Stock shares
Shares sold 30,263 shares Sale of Series C Common Stock on August 19, 2026
Reported weighted average sale price $52.84 per share Weighted average price for sale of 30,263 shares of Series C Common Stock
Sale price range $52.24 to $53.66 per share Range of prices for the reported sale transactions, as disclosed in footnote
Rule 10b5-1 plan adoption date May 18, 2026 Date Jill L. Robinson adopted the Rule 10b5-1 sales plan governing these transactions
Option expiration date December 10, 2027 Expiration date of the exercised stock option
Derivative shares following exercise 0 shares Total derivative securities remaining for the reported option after exercise
Rule 10b5-1 sales plan regulatory
"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan"
weighted average sale price financial
"Reflects the weighted average sale price. The range of prices for such transaction"
Series C Common Stock financial
"underlying_security_title": "Series C Common Stock"
Series C common stock is a specific class of a company’s ordinary shares that is labeled “Series C” to distinguish its rights and history from other share classes. Investors should care because these shares can carry different voting power, dividend rules, or priority if the company is sold, so owning Series C is like having a particular model of a product with slightly different features that affect control, payout and value compared with other share classes.
Stock option (Right to Buy) financial
"security_title": "Stock option (Right to Buy) - BATRK"

FAQ

What insider transaction did BATRA report for Jill L. Robinson?
Jill L. Robinson exercised options for 30,263 shares of Series C Common Stock at an exercise price of $27.18 per share and sold 30,263 shares on August 19, 2026 under a Rule 10b5-1 sales plan.

At what prices were Jill L. Robinson’s BATRA shares sold?
The reported sale used a weighted average sale price of $52.84 per share, with an actual price range from $52.24 to $53.66. Full details by individual sale price are available upon request to the issuer, the SEC staff, or any security holder.

What options did Jill L. Robinson exercise in the BATRA Form 4?
She exercised a stock option for 30,263 shares of Series C Common Stock at an exercise price of $27.18 per share. The option had an original expiration date of December 10, 2027 and is shown with 0 derivative shares remaining after exercise.

Were Jill L. Robinson’s BATRA trades made under a Rule 10b5-1 plan?
Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 sales plan adopted by Jill L. Robinson on May 18, 2026, and the plan status checkbox is marked as affirmed.

How many BATRA shares did Jill L. Robinson sell in this Form 4?
She sold 30,263 shares of Series C Common Stock in a transaction coded as a sale (S) on August 19, 2026, following the exercise of the same number of stock options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Robinson Jill L.
(Last)(First)(Middle)
C/O ATLANTA BRAVES HOLDINGS, INC.
755 BATTERY AVENUE SE
(Street)
ATLANTA GEORGIA 30339
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Atlanta Braves Holdings, Inc. [ BATRK ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, CFO & Treasurer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Series C Common Stock08/19/2026M30,263A$27.18109,723D
Series C Common Stock08/19/2026S(1)30,263D$52.84(2)79,460D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock option (Right to Buy) - BATRK$27.1808/19/2026M(1)30,26312/10/202312/10/2027Series C Common Stock30,263$00D
Explanation of Responses:
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2026.
2. Reflects the weighted average sale price. The range of prices for such transaction is $52.24 to $53.66. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
/s/ Greg Heller, Attorney-in-Fact08/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR